Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
1
x
$
30.00
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
1
x
$
30.00
Letter From the Editors: A Question of Ownership
1
x
$
0.00
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
1
x
$
30.00
Mechanism of Action of Antidepressants
1
x
$
30.00
VOL 2 No. 2 Full Issue - February 2000
1
x
$
20.00
Atomoxetine Induced Hypothermia by Onat Yilmaz
1
x
$
30.00
Sleep Deprivation & Amphetamine Induced Psychosis
1
x
$
30.00
Zung Self-Rating Depression Scale
1
x
$
0.00
Mikael Landén, MD, PhD: Treatment Refractory Psychosis Remitted Upon Treatment with Continuous Positive Airway Pressure: A Case Report
1
x
$
30.00
View Cart
Checkout
Home
schizophrenia
“Mikael Landén, MD, PhD: Treatment Refractory Psychosis Remitted Upon Treatment with Continuous Positive Airway Pressure: A Case Report” has been added to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Gender and Schizophrenia
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
$
0.00
Add to cart
Details
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
$
0.00
Add to cart
Details
Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia – A Reference Guide
$
0.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Clozapine Factors in Schizophrenia by Takefumi Suzuki
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Treatment with Olanzapine: Early Predictors of Weight Gain Risk
$
30.00
Add to cart
Details
Takefumi Suzuki – Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
$
30.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Schizophrenia and Valproate
$
30.00
Add to cart
Details
1
2
…
4
Next
Page load link
Go to Top
